(Q35087655)

6 August 2017

1 reference

title

Measurement of somatic neuropathy for clinical practice and clinical trials (English)

1 reference

6 August 2017

Scott LV

1

1 reference

6 August 2017

Tesfaye S

series ordinal

2

1 reference

6 August 2017

publication date

1 December 2001

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

208-215

1 reference

Chronic neuropathic pain: mechanisms and treatment

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Psychological aspects of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0036-4

Is ACE Inhibition with Lisinopril Helpful in Diabetic Neuropathy?

21 January 2018

1 reference

12 December 2020

A case of hand ulceration in the diabetic foot clinic--a reminder of hand neuropathy in 'at risk' patients.

1 reference

12 December 2020

Gabapentin therapy for diabetic neuropathic pain

1 reference

12 December 2020

Spinal-cord involvement in diabetic peripheral neuropathy

1 reference

12 December 2020

Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial

1 reference

12 December 2020

Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics

1 reference

12 December 2020

Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy

1 reference

12 December 2020

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

1 reference

12 December 2020

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

12 December 2020

The evolving role of antiepileptic drugs in treating neuropathic pain

1 reference

12 December 2020

Sural nerve conduction velocity and refractory period in diabetics without clinical signs of neuropathy

1 reference

12 December 2020

The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic

1 reference

12 December 2020

NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

12 December 2020

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

12 December 2020

Testing of the refractory period in sensory nerve fibres is the most sensitive method to assess beginning polyneuropathy in diabetics

1 reference

12 December 2020

Lowering the risk of neuropathy, foot ulcers and amputations

1 reference

12 December 2020

A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

12 December 2020

Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects

1 reference

12 December 2020

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Correlation between nerve conduction studies and clinical scores in diabetic neuropathy

1 reference

12 December 2020

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

1 reference

12 December 2020

F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy

1 reference

12 December 2020

Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy

1 reference

12 December 2020

Discomfort after fascicular sural nerve biopsy

1 reference

12 December 2020

Reproducibility of different nerve conduction velocity measurements in healthy test subjects and patients suffering from diabetic polyneuropathy

1 reference

12 December 2020

Detection, characterization, and staging of polyneuropathy: assessed in diabetics

1 reference

12 December 2020

Protein kinase C activation and the development of diabetic complications

1 reference

12 December 2020

The 'VPTscore'--a useful predictor of neuropathy in diabetic patients

1 reference

12 December 2020

Hypertension as a risk factor for diabetic neuropathy: a prospective study

1 reference

12 December 2020

Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements.

1 reference

12 December 2020

Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?

1 reference

12 December 2020

A comparison of electrophysiological tests for the early diagnosis of diabetic neuropathy

1 reference

12 December 2020

Glycation products and the pathogenesis of diabetic complications

1 reference

12 December 2020

Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy

1 reference

12 December 2020

Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients

1 reference

12 December 2020

The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study

1 reference

12 December 2020

Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibres

1 reference

12 December 2020

Clinical trials for polyneuropathy: the role of nerve conduction studies, quantitative sensory testing, and autonomic function testing

1 reference

12 December 2020

Vibration Perception Threshold: Influence of Age, Height, Sex, and Smoking, and Calculation of Accurate Centile Values

1 reference

12 December 2020

Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group

1 reference

12 December 2020

Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests

1 reference

12 December 2020

The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes

1 reference

12 December 2020

Diagnostic sensitivity of predicted F-wave latency by age, height, and MCV.

1 reference

12 December 2020

The treatment of chronic pain by epidural spinal cord stimulation--a 15 year follow up; present status.

1 reference

12 December 2020

The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy

1 reference

12 December 2020

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

12 December 2020

A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting

1 reference

12 December 2020

Diabetic peripheral neuropathy and quality of life

1 reference

12 December 2020

Conduction studies as prognostic parameters in the natural history of diabetic neuropathy: a long-term follow-up of 114 patients

1 reference

12 December 2020

Sensory testing versus nerve conduction velocity in diabetic polyneuropathy

1 reference

12 December 2020

The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy

1 reference

12 December 2020

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

1 reference

12 December 2020

Psychological assessment and treatment of patients with neuropathic pain

1 reference

12 December 2020

Variance of sensory threshold measurements: discrimination of feigners from trustworthy performers

1 reference

12 December 2020

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-001-0036-4

Identifiers

DOI

1 reference

6 August 2017

1 reference